Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of IA vs. IA+EA LP-PRP for Hip Osteoarthritis
NCT04241354Phase 1Unknown
- Sponsor
- Regenerative Orthopedics and Sports Medicine
- Start
- Aug 2021
- Primary completion
- Dec 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, randomised trial of leukocyte-poor platelet-rich plasma in osteoarthritis (OA) (2 arms), sponsored by Regenerative Orthopedics and Sports Medicine. Primary endpoints: Hip Osteoarthritis Outcome Score for Joint Replacement at 12 months and Numeric Rating Scale at 12 months. Status: unknown.
02
Drugs
leukocyte-poor platelet-rich plasma
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04241354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04241354.